Sec. 562.006. LABEL. (a) Unless otherwise directed by the practitioner, the label on the dispensing container must indicate the actual drug or biological product dispensed, indicated by either:
(1) the brand name; or
(2) if there is not a brand name, the drug's generic name or the name of the biological product, the strength of the drug or biological product, and the name of the manufacturer or distributor of the drug or biological product.
(b) In addition to the information required by Subsection (a), the label on the dispensing container of a drug or biological product dispensed by a Class A or Class E pharmacy must indicate:
(1) the name, address, and telephone number of the pharmacy;
(2) the date the prescription is dispensed;
(3) the name of the prescribing practitioner;
(4) the name of the patient or, if the drug or biological product was prescribed for an animal, the species of the animal and the name of the owner;
(5) instructions for use;
(6) the quantity dispensed;
(7) if the drug or biological product is dispensed in a container other than the manufacturer's original container, the date after which the prescription should not be used, determined according to criteria established by board rule based on standards in the United States Pharmacopeia-National Formulary; and
(8) any other information required by board rule.
(c) The information required by Subsection (b)(7) may be recorded on any label affixed to the dispensing container.
(d) Subsection (b) does not apply to a prescription dispensed to a person at the time of release from prison or jail if the prescription is for not more than a 10-day supply of medication.
(e) If a drug or biological product has been selected other than the one prescribed, the pharmacist shall place on the container the words "Substituted for brand prescribed" or "Substituted for 'brand name'" where "brand name" is the name of the brand name drug or biological product prescribed.
(f) The board shall adopt rules requiring the label on a dispensing container to be in plain language and printed in an easily readable font size for the consumer.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.
Amended by:
Acts 2007, 80th Leg., R.S., Ch. 457 (H.B. 948), Sec. 1, eff. September 1, 2007.
Acts 2009, 81st Leg., R.S., Ch. 289 (H.B. 19), Sec. 1, eff. September 1, 2009.
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 6, eff. September 1, 2015.
Structure Texas Statutes
Subtitle J - Pharmacy and Pharmacists
Chapter 562 - Practice by License Holder
Subchapter A. Prescription and Substitution Requirements
Section 562.002. Legislative Intent
Section 562.003. Disclosure of Price; Patient's Option
Section 562.004. Prescription Transmitted Orally by Practitioner
Section 562.005. Record of Dispensed Drug or Biological Product
Section 562.0051. Communication Regarding Certain Dispensed Biological Products
Section 562.0061. Other Prescription Information
Section 562.0062. Required Statement Regarding Medication Disposal
Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized
Section 562.012. Substitution of Dosage Form Permitted
Section 562.013. Applicability of Subchapter
Section 562.014. Narrow Therapeutic Index Drugs
Section 562.0141. Transplant Immunosuppressant Drug Product Selection Prohibited
Section 562.0142. Adoption of Rules
Section 562.015. Dispensing Directive; Compliance With Federal Law
Section 562.016. List of Approved Interchangeable Biological Products